GB1126892A - Medicinal preparations for the treatment of prostatic hypertrophy - Google Patents

Medicinal preparations for the treatment of prostatic hypertrophy

Info

Publication number
GB1126892A
GB1126892A GB13103/66A GB1310366A GB1126892A GB 1126892 A GB1126892 A GB 1126892A GB 13103/66 A GB13103/66 A GB 13103/66A GB 1310366 A GB1310366 A GB 1310366A GB 1126892 A GB1126892 A GB 1126892A
Authority
GB
United Kingdom
Prior art keywords
treatment
prostatic hypertrophy
medicinal preparations
march
esters
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB13103/66A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of GB1126892A publication Critical patent/GB1126892A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB13103/66A 1965-03-24 1966-03-24 Medicinal preparations for the treatment of prostatic hypertrophy Expired GB1126892A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DESC036759 1965-03-24

Publications (1)

Publication Number Publication Date
GB1126892A true GB1126892A (en) 1968-09-11

Family

ID=7433992

Family Applications (1)

Application Number Title Priority Date Filing Date
GB13103/66A Expired GB1126892A (en) 1965-03-24 1966-03-24 Medicinal preparations for the treatment of prostatic hypertrophy

Country Status (5)

Country Link
US (1) US3541209A (OSRAM)
BE (1) BE678366A (OSRAM)
FR (1) FR5425M (OSRAM)
GB (1) GB1126892A (OSRAM)
NL (1) NL151903B (OSRAM)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6699847B2 (en) 1998-12-16 2004-03-02 Pfizer Inc. Antiparasitic formulation
US6774122B2 (en) 2000-01-10 2004-08-10 Astrazeneca Ab Formulation

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8951996B2 (en) 2011-07-28 2015-02-10 Lipocine Inc. 17-hydroxyprogesterone ester-containing oral compositions and related methods
MX2017016823A (es) 2015-06-22 2018-03-12 Lipocine Inc Composiciones orales que contienen éster de 17- hydroxiprogesterona y métodos relacionados.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1074582B (de) * 1960-02-04 Schering Aktiengesellschaft, Ber Im Verfahren zur Herstellung progesteronartig wirksamer Steroide mit bisher unerreichter Hohe der Wirksamkeit
GB876902A (en) * 1957-03-09 1961-09-06 Syntex Sa New cyclopentanophenanthrene derivatives and process for the production thereof

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6699847B2 (en) 1998-12-16 2004-03-02 Pfizer Inc. Antiparasitic formulation
US6774122B2 (en) 2000-01-10 2004-08-10 Astrazeneca Ab Formulation
US7456160B2 (en) 2000-01-10 2008-11-25 Astrazeneca Ab Formulation
US8329680B2 (en) 2000-01-10 2012-12-11 Astrazeneca Ab Formulation
US8466139B2 (en) 2000-01-10 2013-06-18 Astrazeneca Ab Formulation

Also Published As

Publication number Publication date
US3541209A (en) 1970-11-17
NL6603833A (OSRAM) 1966-09-26
NL151903B (nl) 1977-01-17
BE678366A (OSRAM) 1966-09-26
FR5425M (OSRAM) 1967-10-02

Similar Documents

Publication Publication Date Title
GB1126892A (en) Medicinal preparations for the treatment of prostatic hypertrophy
GB1164705A (en) Preparation of Delta<7>-Dehydro Steroids
GB1213118A (en) PROCESS FOR PREPARING 9alpha-FLUORO-16-METHYLENE-PREDNISOLONE OR PREDNISONE, AND 21-ESTERS THEREOF
CA687540A (en) Process of preparing fatty acid esters of hydroxyalkane sulfonic acids
GB1215164A (en) 21-sulphonated pregnadienes
CA627197A (en) Aminocarboxylic acid esters of hydroxy steroids
CA687539A (en) Esters of 3,4-epoxycyclohexanecarboxylic acids and process for their preparation
GB1145651A (en) A novel pregnane derivative
CA626822A (en) PROCESS OF PRODUCING TEREPHTHALIC ACID MONO-(.beta.-HYDROXY ETHYL) ESTER AND ITS METAL SALTS
AU268210B2 (en) Esters of farresyl acetic acid
CA692227A (en) 21-DICARBOXYLIC ACID ESTERS OF 16.alpha.,17.alpha.-ACETAL AND KETAL DERIVATIVES OF STEROIDS
CA690382A (en) Esters of 3,4-epoxy-cyclohexane-carboxylic acids and process for their preparation
CA624944A (en) Preparation of carboxylic acid esters
CA680811A (en) Carboxylic acid containing thio ethers of 3,20-diketo pregnane, pregnene and pregnadiene compounds
AU1714762A (en) Esters of farresyl acetic acid
CA678412A (en) 21-carboxylic acid esters of pregnane compounds
ES394771A1 (es) Procedimiento para la preparacion de 17 alfa - hidroxi -16 alfa, 18 - dimetil-4-pregnen-3,20-diona y sus 17 alfa-mono- esteres o 9-enol - 17 alfa - diesteres.
GB1174358A (en) 6-Methyl-16-Methylene-21-Fluoro-Steroids of the Pregnane Series.
CA735902A (en) Hydroxycarboxylic acid esters of the pregnane series and process for preparing them
CA619331A (en) Production of carboxylic acids, their esters and salts
AU280966B2 (en) Process for the preparation of esters of unsaturated aliphatic carboxylic acids
CA625142A (en) Process for the preparation of esters of alicyclyl-alicyclic carboxylic acids
GB1134072A (en) 3-unsubstituted steroids
GB1066658A (en) Oxido androstanes
GB1230671A (OSRAM)